Swedish Cancer Institute Research — Seattle, Washington

Swedish Cancer Institute Research is a clinical research site located in Seattle, Washington, United States 98104.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Swedish Cancer Institute Research has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer With Low to Intermediate HER2 Expression, Metastatic Castration-Resistant Prostate Cancer, Prostate Cancer.

Sponsors: Galena Biopharma, Inc., POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company, Endocyte.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Swedish Cancer Institute Research?

Swedish Cancer Institute Research has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Swedish Cancer Institute Research conducted?

Swedish Cancer Institute Research has 3 clinical trials on record, with 1 currently active. Their work covers Breast Cancer With Low to Intermediate HER2 Expression, Metastatic Castration-Resistant Prostate Cancer, Prostate Cancer.

Is Swedish Cancer Institute Research accredited by Crixeo Health?

Swedish Cancer Institute Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Swedish Cancer Institute Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.